Evidence map›Paper›PMID 39360411›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

SPA Promotes Atherosclerosis Through Mediating Macrophage Foam Cell Formation-Brief Report.

Skylar D King, Dunpeng Cai, Alisha Pillay, Mikayla M Fraunfelder, Lee-Ann H Allen, Shi-You Chen

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Skylar D King *Department of Surgery (S.D.K., D.C., M.M.F., S.-Y.C.), University of Missouri School of Medicine, Columbia.ORCID 0000-0002-4150-7807
Dunpeng Cai *Department of Surgery (S.D.K., D.C., M.M.F., S.-Y.C.), University of Missouri School of Medicine, Columbia.ORCID 0000-0002-0489-6567
Alisha PillayDepartment of Molecular Microbiology and Immunology (A.P., L.-A.H.A.), University of Missouri School of Medicine, Columbia.
Mikayla M FraunfelderDepartment of Surgery (S.D.K., D.C., M.M.F., S.-Y.C.), University of Missouri School of Medicine, Columbia.
Lee-Ann H AllenDepartment of Molecular Microbiology and Immunology (A.P., L.-A.H.A.), University of Missouri School of Medicine, Columbia.ORCID 0000-0001-8929-6968
Shi-You ChenDepartment of Surgery (S.D.K., D.C., M.M.F., S.-Y.C.), University of Missouri School of Medicine, Columbia.ORCID 0000-0002-0297-8649

Funding

Fortilin, p53, and atherosclerosisR01HL117247 · NHLBI · UNIVERSITY OF WASHINGTON · PI CHEN, SHIYOU, FUJISE, KEN · 2013 to 2023
$4.7M
Novel mechanism of smooth muscle phenotypic modulation and vascular remodelingR01HL119053 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHEN, SHIYOU · 2014 to 2023
$3.8M
Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosisR01HL151444 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI BOWLES, DOUGLAS K · 2022 to 2025
$2.6M
Dedicator of cytokinesis 2 in abdominal aortic aneurysmR01HL147313 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHEN, SHIYOU · 2019 to 2022
$2.1M
Novel Mechanisms underlying abdominal aortic aneurysm progressionR01HL173025 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI Shiyou Chen · 2024 to 2026
$1.9M
The mechanistic role of surfactant protein A in smooth muscle cell phenotype modulation and vascular remodelingF32HL159930 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI KING, SKYLAR DAWN · 2021 to 2024
$249k
Novel Mechanisms Underlying the Development of AtherosclerosisI01BX006161 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Shiyou Chen · 2023 to 2026
–
BLRD VA I01 BX006161NHLBI NIH HHS F32 HL159930NHLBI NIH HHS L30 HL170340NHLBI NIH HHS R01 HL117247NHLBI NIH HHS R01 HL119053NHLBI NIH HHS R01 HL147313NHLBI NIH HHS R01 HL151444NHLBI NIH HHS R01 HL173025
6 · The paper itself

Abstract

backgroundAtherosclerosis is a progressive inflammatory disease in which macrophage foam cells play a central role in disease pathogenesis. SPA (surfactant protein A) is a lipid-associating protein involved with regulating macrophage function in various inflammatory diseases. However, the role of SPA in atherosclerosis and macrophage foam cell formation has not been investigated.

methodsSPA expression was assessed in healthy and atherosclerotic human coronary arteries and the brachiocephalic arteries of wild-type or ApoE-deficient mice fed high-fat diets for 4 weeks. Hypercholesteremic wild-type and SPA-deficient mice fed a high-fat diet for 6 weeks were investigated for atherosclerotic lesions in vivo. In vitro experiments using RAW264.7 macrophages, primary resident peritoneal macrophages extracted from wild-type or SPA-deficient mice, and human monocyte-derived macrophages from the peripheral blood of healthy donors determined the functional effects of SPA in macrophage foam cell formation.

resultsSPA expression was increased in atherosclerotic lesions in humans and ApoE-deficient mice and in response to a proatherosclerotic stimulus in vitro. SPA deficiency reduced the lipid profiles induced by hypercholesterolemia, attenuated atherosclerosis, and reduced the number of lesion-associated macrophage foam cells. In vitro studies revealed that SPA deficiency reduced intracellular cholesterol accumulation and macrophage foam cell formation. Mechanistically, SPA deficiency dramatically downregulated the expression of scavenger receptor CD36 (cluster of differentiation antigen 36) cellular and lesional expression. Importantly, SPA also increased CD36 expression in human monocyte-derived macrophages.

conclusionsOur results elucidate that SPA is a novel factor promoting atherosclerosis development. SPA enhances macrophage foam cell formation and atherosclerosis by increasing scavenger receptor CD36 expression, leading to increasing cellular OxLDL influx.

Indexed as

AtherosclerosisFoam CellsPlaque, AtheroscleroticPulmonary Surfactant-Associated Protein AAnimalsCD36 AntigensCells, CulturedCholesterolDiet, High-FatDisease Models, AnimalFemaleHumansLipoproteins, LDLMacrophages, PeritonealMaleMiceCD36 AntigensCD36 protein, humanCd36 protein, mouseCholesterolLipoproteins, LDLPulmonary Surfactant-Associated Protein Aatherosclerosischolesterollipoproteins, LDLmacrophagesreceptors, scavenger

Identifiers

PMID39360411
PMCPMC11499019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.